42
Participants
Start Date
February 28, 2002
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
filgrastim
480 mcg beginning day +5
busulfan
11.2 mg/kg; 0.8 mg/kg IV q6h X 14 doses
cyclophosphamide
60 mg/kg IV over 2 hours x 2 days
etoposide
60 mg/kg, IV
melphalan
150mg/m2 in NS at a concentration of 0.4mg/cc infused over 60 minutes.
autologous-autologous tandem hematopoietic stem cell transplantation
autologous-autologous tandem hematopoietic stem cell transplantation
radiation therapy
radiation therapy
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
National Cancer Institute (NCI)
NIH
Case Comprehensive Cancer Center
OTHER